Liver Centre, Toronto Western Hospital, University Health Network and Department of Medicine, University of Toronto, Toronto, Canada.
Hepatology. 2010 Aug;52(2):562-70. doi: 10.1002/hep.23683.
Quality of life is an important concern for patients with chronic liver disease. We sought to describe the frequency, severity, and associations of fatigue, in patients with primary biliary cirrhosis (PBC). We performed association testing between PBC-40 multidomain disease-specific quality of life responses and clinical findings. Three hundred twenty-seven patients from a single clinic with PBC (94% female, 92% AMA-positive) were evaluated. The average age was 57 years and average disease duration 7.2 years. Verbally reported fatigue was noted in 48% but present in the overwhelming majority on PBC-40 completion, with 44% having moderate or severe symptoms. Of those not complaining of fatigue clinically, 25% documented moderate or severe fatigue by questionnaire. Age had an inverse relationship with fatigue (P < 0.01), whereas body mass index (BMI) was positively associated (P < 0.01), as was the presence of pruritus (P < 0.001), sicca symptoms (P < 0.001), depression (P < 0.001), fibromyalgia (P < 0.004), and scleroderma (P < 0.05). For those with varices (P < 0.05) or cirrhosis clinically (P < 0.05), higher fatigue scores were noted, although those who initially presented with noncirrhotic disease had higher scores at the time of testing (P < 0.005). Fatigue was associated with greater use of prescription medication (P < 0.01), in particular for antipruritics (cholestyramine: P < 0.001; rifampin: P < 0.001), proton pump inhibitors (P < 0.002), beta-blockers (P < 0.02), and antidepressants (P < 0.001), whereas those taking calcium and vitamin D appeared less fatigued (P < 0.05). In a multivariate model, calcium and vitamin D use, BMI, stage of disease at diagnosis, as well as symptomatic fatigue or pruritus, were significant. Biochemical response to UDCA was not associated with lower fatigue scores.
Attempts at defining the biological basis of fatigue in patients with PBC, and improving its treatment, must account for its multifactoral causes.
生活质量是慢性肝病患者关注的重要问题。我们旨在描述原发性胆汁性肝硬化(PBC)患者的疲劳频率、严重程度及其相关性。我们对 PBC-40 多领域疾病特异性生活质量反应与临床发现之间进行了关联测试。对来自单一诊所的 327 名 PBC 患者(94%女性,92%AMA 阳性)进行了评估。平均年龄为 57 岁,平均病程为 7.2 年。口头报告的疲劳在 48%的患者中存在,但在 PBC-40 完成时绝大多数患者存在疲劳,其中 44%的患者有中度或重度症状。在临床上未报告疲劳的患者中,25%的患者通过问卷记录了中度或重度疲劳。年龄与疲劳呈负相关(P<0.01),而体重指数(BMI)与疲劳呈正相关(P<0.01),瘙痒(P<0.001)、干燥症状(P<0.001)、抑郁(P<0.001)、纤维肌痛(P<0.004)和硬皮病(P<0.05)也与疲劳呈正相关。对于有静脉曲张(P<0.05)或临床上有肝硬化的患者(P<0.05),疲劳评分较高,但那些最初表现为非肝硬化疾病的患者在测试时的评分更高(P<0.005)。疲劳与更多处方药的使用相关(P<0.01),特别是抗瘙痒药(考来烯胺:P<0.001;利福平:P<0.001)、质子泵抑制剂(P<0.002)、β-受体阻滞剂(P<0.02)和抗抑郁药(P<0.001),而服用钙和维生素 D 的患者疲劳程度较低(P<0.05)。在多变量模型中,钙和维生素 D 的使用、BMI、诊断时疾病的阶段,以及有症状的疲劳或瘙痒,都是显著的。UDCA 治疗的生化反应与疲劳评分的降低无关。
要确定 PBC 患者疲劳的生物学基础,并改善其治疗,必须考虑其多因素病因。